From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Aldosterone-Renin Ratio in Primary Hyperaldosteronism

Determining the ARR was enough to confirm or exclude diagnoses of primary aldosteronism in some, but not all, cases; it's probably best to make sure that patients are evaluated by experienced physicians.

The aldosterone-renin ratio (ARR) has gained popularity as a screening test for primary hyperaldosteronism, a probably underdiagnosed cause of hypertension. However, studies have yielded varying definitions of a positive test.

In this retrospective study from Hong Kong, researchers analyzed results from 62 patients referred to a hospital's endocrine unit with suspected primary hyperaldosteronism (usually because of hypertension plus hypokalemia). Final diagnoses were based on surgical pathology, saline suppression tests, computed tomography findings, and adrenal venous sampling (not all patients underwent all tests). ARRs were determined in each patient after overnight recumbency, after sitting for 30 minutes, and after 4 hours of ambulation.

Primary hyperaldosteronism ultimately was diagnosed in 45 patients; the other 17 were presumed to have essential hypertension. After reviewing all ARR results, the authors conclude that testing patients after 30 minutes seated is acceptable for screening. An ARR cutoff of 23.6 ng/dL per ng/mL · hour had a sensitivity of 97% and specificity of 94%. A cutoff of 66.9 yielded 100% specificity: All patients with levels above this cutoff had primary hyperaldosteronism. The median ARR was 136.4 among patients with hyperaldosteronism and 5.6 among controls.

Comment: In this study, an ARR >66.9 after 30 minutes seated confirmed primary hyperaldosteronism, whereas an ARR <23.6 excluded it with near certainty. Between these two cutoffs, additional tests were needed to confirm or exclude the diagnosis. Because of other important variables (e.g., performance of specific test kits, differing patient populations across studies), it's probably best to have patients evaluated by physicians with experience in diagnosing primary hyperaldosteronism.

— Allan S. Brett, MD

Published in Journal Watch General Medicine February 11, 2005

Citation(s):

Tiu S-C et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005 Jan; 90:72-8.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.